Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01731054 · ClinicalTrials.gov registry record

Functional MRI in Lupus Nephritis

A clinical trial, sponsored by Biogen.

Completed
Registry status
50
Enrollment target

NCT01731054: Completed study, sponsored by Biogen.

NCT01731054 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01731054 has completed, sponsored by Biogen.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The primary objectives of the study are as follows: To develop and optimize a renal functional magnetic resonance imaging (MRI) protocol consisting of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI), Blood-Oxygen- Level-Dependent MRI (BOLD-MRI), Arterial Spin Labeling MRI (ASL-MRI), Phase Contrast MRI (PC-MRI), and T1rho-MRI; To compare renal functional MRI cross-sectional readouts between normal healthy volunteers (NHV) and lupus nephritis (LN) participants. The secondary objectives of this study are as follows: Explore whether renal functional MRI techniques discriminate between renal inflammatory activity and damage in lupus nephritis (LN); To examine whether renal functional MRI measurements correlate with laboratory features of renal involvement and renal function in participants with lupus nephritis (LN).

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-06
Est. Completion 2015-03
Biogen

334 total trials

What the finished NCT01731054 record still lists

NCT01731054 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01731054 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01731054 about?

NCT01731054 is a clinical study titled "Functional MRI in Lupus Nephritis". The primary objectives of the study are as follows: To develop and optimize a renal functional magnetic resonance imaging (MRI) protocol consisting of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI), Blood-Oxygen- Level-Dependent MRI (BOLD-MRI), Arterial Spin Labeling MRI (ASL-MRI), Phase Con...

What is the current status of trial NCT01731054?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-06. Estimated completion is 2015-03.

Who is sponsoring clinical trial NCT01731054?

This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01731054, the US trial registry maintained by the National Library of Medicine. NCT01731054 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.